Clinical Characteristics of Reports Associated with TAF from the FAERS Database.
<p>Clinical Characteristics of Reports Associated with TAF from the FAERS Database.</p>
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1852019600887119872 |
|---|---|
| author | Chao Zhang (51048) |
| author2 | Jiaqi Wen (6838376) Yinghui Li (237776) |
| author2_role | author author |
| author_facet | Chao Zhang (51048) Jiaqi Wen (6838376) Yinghui Li (237776) |
| author_role | author |
| dc.creator.none.fl_str_mv | Chao Zhang (51048) Jiaqi Wen (6838376) Yinghui Li (237776) |
| dc.date.none.fl_str_mv | 2025-06-05T17:53:34Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0324675.t001 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Clinical_Characteristics_of_Reports_Associated_with_TAF_from_the_FAERS_Database_/29250090 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Pharmacology Biotechnology Cancer Mental Health Infectious Diseases Virology world disproportionality analysis reporting odds ratio hepatitis b virus enhance patient adherence 57692002 case reports management protocols especially adverse events associated 1911 reported taf term tenofovir alafenamide mitigate resistance risks faers )</ p term management tenofovir alafenamide adverse events related risks xlink "> worth noting uneven distribution thereby necessitating swallowing difficulties safety characteristics research objective providing support prioritize strengthening practical settings poisson shrinker neurological symptoms marketing evidence marked increase major suspected lipid profiles healthcare providers faers database etc ., drug resistance drug administration database maintained clinical vigilance cerebral infarction bone pain benefit balance bcpnn ), analyzing data aes ). |
| dc.title.none.fl_str_mv | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Clinical Characteristics of Reports Associated with TAF from the FAERS Database.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_a032a62563ff92ebe4d0e0d4ffab8a52 |
| identifier_str_mv | 10.1371/journal.pone.0324675.t001 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/29250090 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Clinical Characteristics of Reports Associated with TAF from the FAERS Database.Chao Zhang (51048)Jiaqi Wen (6838376)Yinghui Li (237776)MedicinePharmacologyBiotechnologyCancerMental HealthInfectious DiseasesVirologyworld disproportionality analysisreporting odds ratiohepatitis b virusenhance patient adherence57692002 case reportsmanagement protocols especiallyadverse events associated1911 reported tafterm tenofovir alafenamidemitigate resistance risksfaers )</ pterm managementtenofovir alafenamideadverse eventsrelated risksxlink ">worth notinguneven distributionthereby necessitatingswallowing difficultiessafety characteristicsresearch objectiveproviding supportprioritize strengtheningpractical settingspoisson shrinkerneurological symptomsmarketing evidencemarked increasemajor suspectedlipid profileshealthcare providersfaers databaseetc .,drug resistancedrug administrationdatabase maintainedclinical vigilancecerebral infarctionbone painbenefit balancebcpnn ),analyzing dataaes ).<p>Clinical Characteristics of Reports Associated with TAF from the FAERS Database.</p>2025-06-05T17:53:34ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0324675.t001https://figshare.com/articles/dataset/Clinical_Characteristics_of_Reports_Associated_with_TAF_from_the_FAERS_Database_/29250090CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/292500902025-06-05T17:53:34Z |
| spellingShingle | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. Chao Zhang (51048) Medicine Pharmacology Biotechnology Cancer Mental Health Infectious Diseases Virology world disproportionality analysis reporting odds ratio hepatitis b virus enhance patient adherence 57692002 case reports management protocols especially adverse events associated 1911 reported taf term tenofovir alafenamide mitigate resistance risks faers )</ p term management tenofovir alafenamide adverse events related risks xlink "> worth noting uneven distribution thereby necessitating swallowing difficulties safety characteristics research objective providing support prioritize strengthening practical settings poisson shrinker neurological symptoms marketing evidence marked increase major suspected lipid profiles healthcare providers faers database etc ., drug resistance drug administration database maintained clinical vigilance cerebral infarction bone pain benefit balance bcpnn ), analyzing data aes ). |
| status_str | publishedVersion |
| title | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| title_full | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| title_fullStr | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| title_full_unstemmed | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| title_short | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| title_sort | Clinical Characteristics of Reports Associated with TAF from the FAERS Database. |
| topic | Medicine Pharmacology Biotechnology Cancer Mental Health Infectious Diseases Virology world disproportionality analysis reporting odds ratio hepatitis b virus enhance patient adherence 57692002 case reports management protocols especially adverse events associated 1911 reported taf term tenofovir alafenamide mitigate resistance risks faers )</ p term management tenofovir alafenamide adverse events related risks xlink "> worth noting uneven distribution thereby necessitating swallowing difficulties safety characteristics research objective providing support prioritize strengthening practical settings poisson shrinker neurological symptoms marketing evidence marked increase major suspected lipid profiles healthcare providers faers database etc ., drug resistance drug administration database maintained clinical vigilance cerebral infarction bone pain benefit balance bcpnn ), analyzing data aes ). |